RESEARCH PROJECTS
At defeatHIV, our top priority is to achieve results, and we know that our success depends on the quality of our collaborations and partnerships. Our approach is to build strategic networks between scientists and community, or between academia, industry and the clinic that will help advance our work towards an HIV cure accessible to everyone who needs it. Learn more about the science we’re passionate about and get in touch with us to see how you can get involved.
HIV-RESISTANT ANTI-HIV
CAR T CELLS
IRF1 Leaders & Industry Partners:
Lawrence Corey, MD, Fred Hutchinson Cancer Research Center • Seattle, Washington
David Rawlings, MD, Seattle Children’s Hospital • Seattle, Washington
Thor Wagner, MD, Seattle Children’s Hospital • Seattle, Washington
Juno Therapeutics, Seattle, Washington
Gilead Sciences, Foster City, California
Sangamo BioSciences, Richmond, California
ECD4-IG BASED THERAPY FOR HIV CURE
IRF2 Leaders & Industry Partners:
Michael Farzan, PhD, The Scripps Research Institute Florida • Jupiter, Florida
Emmune, Inc., Jupiter, Florida
Gilead Sciences, Foster City, California
GENETIC PROTECTION OF
T CELLS AFTER
THERAPEUTIC VACCINATION
IRF3 Leaders & Industry Partners:
James Mullins, PhD, University of Washington • Seattle, Washington
Deborah Fuller, PhD, University of Washington • Seattle, Washington
Hans-Peter Kiem, MD, PhD, Fred Hutchinson Cancer Research Center • Seattle, Washington
Sangamo BioSciences, Richmond, California
Gilead Sciences, Foster City, California